location: Current position: Home >> Scientific Research >> Paper Publications

Pan-BH3 Mimetic S1 Exhibits Broad-Spectrum Antitumour Effects by Cooperation between Bax and Bak

Hits:

Indexed by:期刊论文

Date of Publication:2013-09-01

Journal:BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Included Journals:SCIE、PubMed、Scopus

Volume:113

Issue:3

Page Number:145-151

ISSN No.:1742-7835

Abstract:Small molecule S1 is a pan-BH3 mimetic that can bind antiapoptotic Bcl-2, Bcl-xL and Mcl-1 proteins. Herein, different Bcl-2 member expression cancer cell lines (NCI-H345, MCF-7, SMMC-7721 and Hela) and cells deficient in Bax and/or Bak by shRNA were used to unravel the cascade of events by which S1 promotes apoptosis compared with Bcl-2/Bcl-xL inhibitor ABT-737. We identified that S1 exhibited broader antitumour spectrum than ABT-737 through disruption of more Bcl-2 interactions including Mcl-1/Bak interaction. Moreover, the individual and combined roles of Bax and Bak in S1-induced apoptosis were revealed. Our results showed that S1 induced a Bak-mediated apoptosis. Bak played a predominant role in either S1 or ABT-737-induced apoptosis through the cooperation with Bax on the formation of large oligomers on mitochondrial membrane.

Pre One:Study of Binding Thermodynamics in the Optimization of BH3 Mimetics

Next One:Mechanisms of anti-leukemic activity of the Bcl-2 homology domain-3 mimetic S1